BenevolentAI: Valuation, Funding & Investors
BenevolentAI is a biotechnology company that applies artificial intelligence and machine learning to accelerate drug discovery and development. The company builds and deploys a knowledge-graph-driven research platform to identify disease mechanisms, prioritize targets, and support compound selection and drug repurposing for biopharma partners and internal programs.
Leadership & Board
- Current Number of Employees
- 69
- Current LinkedIn Followers
- 64,900
Latest Estimated Valuation
- Total Amount Raised
- $90M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $90M
- Latest Funding Round
- Investment
Company Momentum Positive
BenevolentAI LinkedIn following is increasing, signaling rising market interest, while its workforce is growing, indicating business expansion.
Employee Trend
BenevolentAI had 69 employees as of October 26, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
BenevolentAI had 64,900 followers as of October 26, 2026. The number of followers increased by 33 (0.05%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Oct 17, 2019 | Investment | $90.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Temasek Holdings | Investment |
Similar Companies
A snapshot of private companies similar to BenevolentAI, helping you discover and navigate related company profiles.
Related News and Analysis
